Sam Huang

@Checkpoint Capital L.p.

Latest period2024 - Q3

Reported2mo 5d ago

Managed Assets$201.574M

Total holdings16

Assets growth rate21.52%

Assets growth rate (2-Q avg)16.19%

Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Checkpoint Capital L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 16 positions.

Assets under management

The assets under management (AUM) of Checkpoint Capital L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 201.574M in assets, with a quarterly growth rate of 21.52% and a 2-quarter average growth rate of 16.19%. The portfolio is managed by Sam Huang, and others.

Portfolio holdings

Current New Position Increased Decreased Exited

Investment	Portfolio %	Reported Value	Recent Activity
ARGXArgenx Se Recent Activity Increased 12.6%	24.88%	$50.142M 92,500 shares@ $542.08 avg price	Increased 12.6%
PHATPhathom Pharmaceuticals Inc Recent Activity Increased 71.93%	13.5%	$27.198M 1.504M shares@ $18.09 avg price	Increased 71.93%
CYTKCytokinetics Inc Recent Activity Increased 145.7%	12.23%	$24.648M 466,813 shares@ $52.8 avg price	Increased 145.7%
PLRXPliant Therapeutics Inc Recent Activity Increased 63.66%	2.12%	$4.26M 380,000 shares@ $11.21 avg price	Increased 63.66%
SLNOSoleno Therapeutics Inc Recent Activity Increased 194.41%	1.46%	$2.928M 57,983 shares@ $50.5 avg price	Increased 194.41%
CDTXCidara Therapeutics Inc Recent Activity Increased 25.46%	0.98%	$1.961M 182,426 shares@ $10.76 avg price	Increased 25.46%